TAMPA, FL / ACCESSWIRE / January 6, 2017 / Trxade Group, Inc. (OTCQB: TRXD), a web-based market platform with over 6,700
registered independent pharmacy customers that enables its customers to quickly source and purchase pharmaceuticals, accessories,
and services from a wide range of manufacturers and drug distributors, completed the first phase of a comprehensive restructuring
plan designed to refocus the company on its core trading platform.
Today CEO Suren Ajjarapu announced that the Company completed the sale of its wholesale and private label distribution division,
held under its wholly-owned subsidiary, Westminster Pharmaceutical, on December 31, 2016. This restructuring also included a number
of organizational changes and the reduction of debt. With the completion of this sale, Trxade Group, Inc. has refocused its
business strategy to its core business. This restructuring strategy places increased emphasis on Trxade's trading platform and
enhancing revenues in platform monthly sales, payment gateway plans, and category sales for pharmacies in specialty drugs,
controlled drugs, DME's, and OTC products.
"As a result of our refocused business strategy, Trxade Group is better aligned to achieve sustainable long-term growth and
profitability," said Suren Ajjarapu, CEO of Trxade Group, Inc. "We are encouraged by the upward trend in our business levels and,
with the completion of our restructuring plan, we feel we are on a firm financial footing for the long term."
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (OTCQB: TRXD) is a web based market platform that enables trade among
healthcare buyers and sellers of pharmaceuticals, accessories, and services. Founded in 2010, Trxade Group currently operates the
trading platform with over 6700 registered members. For additional information, please visit us at http://www.trxadegroup.com.
Forward-Looking Statements
The information contained herein includes forward-looking statements. These statements relate to future events or to our future
financial performance, and involve known and unknown risks, uncertainties, and other factors that may cause our actual results,
levels of activity, performance, or achievements to be materially different from any future results, levels of activity,
performance, or achievements expressed or implied by these forward-looking statements.
You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties, and
other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results,
levels of activity, performance, or achievements.
Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks,
uncertainties, and assumptions relating to our operations, results of operations, growth strategy, and liquidity. Except as may be
required by applicable law, we assume no obligation to publicly update or revise these forward-looking statements for any reason,
or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if
new information becomes available in the future. The company undertakes no duty to update forward-looking statements.
Investor Relations Contact:
Max Pashman 818-280-6800 mpashman@irpartnersinc.com
SOURCE: Trxade Group, Inc.
